- Troponin up ≠ NSTEMI. Ask: is there acute ischemia from a plaque event (type 1), a supply–demand problem (type 2), or non-ischemic injury?
- Use hs-troponin 0/1-h or 0/2-h pathways. Need a rise and/or fall for acute injury.
- Type 1 NSTEMI: aspirin + anticoagulant (heparin/enoxaparin) + high-intensity statin; P2Y12 per cath timing.
- Cath timing: immediate (<2 h) if unstable · early (<24 h) if high risk (GRACE >140) · before discharge for the rest.
- Type 2 MI: treat the cause (anemia, sepsis, AF-RVR, hypotension). No reflex heparin/cath.
Pathophysiology in 60 seconds
⌄
| Type | Mechanism | Example |
|---|---|---|
| Type 1 MI | Plaque rupture/erosion → partial thrombus | Classic NSTEMI |
| Type 2 MI | O₂ supply/demand mismatch with ischemia | AF-RVR, GI bleed, hypotension |
| Myocardial injury | Troponin up, no ischemia | Sepsis, PE, myocarditis, CKD, HF, stroke |
| Type 3 / 4 / 5 | Sudden death / PCI-related / CABG-related |
Unstable anginaECG: ± ST↓ / T invTroponin: normal
NSTEMIECG: ± ST↓ / T invTroponin: ↑ with rise/fall
STEMIECG: ST↑ or equivalentTroponin: ↑ (do not wait)
One disease (plaque rupture → thrombus), three faces. Ischemia grows left → right. STEMI = total occlusion → open the artery now.
Diagnosis
⌄
MI = rise/fall of troponin (≥1 value >99th percentile) + ischemia (symptoms, new ECG changes, new Q waves, imaging wall-motion loss, or thrombus at angiography).
- hs-cTn algorithms (assay-specific): very low at 0 h (with >3 h of symptoms) → rule out · small delta at 1–2 h → rule out · high value or big delta → rule in · middle → observe, repeat at 3 h.
- ECG: ST depression, T inversion, transient STE. Repeat if pain returns.
- Unstable angina: ischemic symptoms, normal troponin.
| Score | Use |
|---|---|
| HEART (0–10) | ED chest pain: 0–3 low risk → discharge pathway |
| GRACE | NSTE-ACS mortality; >140 → early invasive |
| TIMI (0–7) | Older; simple |
Management (type 1 NSTE-ACS)
⌄
- Aspirin 162–325 mg → 81 mg.
- Anticoagulant: UFH (60 U/kg bolus, 12 U/kg/h) or enoxaparin 1 mg/kg SC q12h (daily if CrCl <30). Fondaparinux needs extra UFH at PCI.
- P2Y12: ticagrelor or prasugrel preferred over clopidogrel. Prasugrel only after anatomy known. If cath will be >24 h away, early clopidogrel or ticagrelor is reasonable (2025).
- High-intensity statin day 1. β-blocker (no HF/shock/bradycardia). Nitro for pain.
| Timing | Who |
|---|---|
| Immediate <2 h | Refractory angina, shock/unstable, VT/VF, acute HF, mechanical complication |
| Early <24 h | GRACE >140, dynamic ST changes, troponin rising quickly |
| Inpatient | Intermediate risk |
| Selective / non-invasive first | Low risk, frail, major bleed risk — shared decision |
- Fix the trigger: transfuse (see anemia page), control AF rate, treat sepsis/hypoxia, stop hypotension.
- Antiplatelet/heparin only if type 1 is still likely.
- Afterwards: outpatient ischemia testing if CAD likely; statin if CAD found.
Pitfalls
⌄
- Heparin drip for every troponin bump (sepsis, CKD, PE).
- Single troponin without a delta.
- Missing posterior MI (ST depression V1–V3 can be an OMI → cath now).
- Stress testing someone with Wellens T waves.
Board corner
⌄
| Stem | Answer |
|---|---|
| GI bleed, Hb 6, troponin up, no chest pain | Type 2 MI → transfuse, treat bleed |
| NSTEMI, refractory chest pain on drip | Immediate cath (<2 h) |
| NSTEMI, GRACE 160, stable | Early invasive within 24 h |
| Troponin elevated, flat, ESRD, no symptoms | Chronic myocardial injury |
| NSTEMI, cath tomorrow, prior ICH | Avoid prasugrel; consider clopidogrel/ticagrelor and bleed risk |
References
⌄
- Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS guideline. 2025.
- Gulati M, et al. 2021 AHA/ACC Chest Pain Guideline. Circulation. 2021;144:e368.
- Thygesen K, et al. Fourth Universal Definition of MI. 2018.